[HTML][HTML] Enhancer-driven lncRNA BDNF-AS induces endocrine resistance and malignant progression of breast cancer through the RNH1/TRIM21/mTOR cascade
X Lin, X Dinglin, S Cao, S Zheng, C Wu, W Chen, Q Li… - Cell reports, 2020 - cell.com
Epigenomic alterations can give rise to various tumor-promoting properties, including
therapeutic resistance of cancer cells. Here, we identify an lncRNA, BDNF-AS, whose …
therapeutic resistance of cancer cells. Here, we identify an lncRNA, BDNF-AS, whose …
[引用][C] Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade
X Lin, X Dinglin, S Cao, S Zheng, C Wu, W Chen, Q Li… - Cell Reports, 2020 - cir.nii.ac.jp
Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression
of Breast Cancer through the RNH1/TRIM21/mTOR Cascade | CiNii Research CiNii 国立情報学 …
of Breast Cancer through the RNH1/TRIM21/mTOR Cascade | CiNii Research CiNii 国立情報学 …
Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade
X Lin, X Dinglin, S Cao, S Zheng, C Wu… - Cell …, 2020 - pubmed.ncbi.nlm.nih.gov
Epigenomic alterations can give rise to various tumor-promoting properties, including
therapeutic resistance of cancer cells. Here, we identify an lncRNA, BDNF-AS, whose …
therapeutic resistance of cancer cells. Here, we identify an lncRNA, BDNF-AS, whose …
[HTML][HTML] Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade
X Lin, X Dinglin, S Cao, S Zheng, C Wu, W Chen, Q Li… - Cell Reports, 2020 - Elsevier
Epigenomic alterations can give rise to various tumor-promoting properties, including
therapeutic resistance of cancer cells. Here, we identify an lncRNA, BDNF-AS, whose …
therapeutic resistance of cancer cells. Here, we identify an lncRNA, BDNF-AS, whose …
Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade.
X Lin, X Dinglin, S Cao, S Zheng, C Wu, W Chen, Q Li… - Cell Reports, 2020 - europepmc.org
Epigenomic alterations can give rise to various tumor-promoting properties, including
therapeutic resistance of cancer cells. Here, we identify an lncRNA, BDNF-AS, whose …
therapeutic resistance of cancer cells. Here, we identify an lncRNA, BDNF-AS, whose …